HeartBeam, Inc. , a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced that it will attend the JP Morgan 2026 Annual Healthcare ...
Background Ebstein’s anomaly (EA) exhibits significant anatomical and clinical heterogeneity, warranting a systematic ...
Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.
Background Annually, 4% of the global population undergoes non-cardiac surgery, with 30% of those patients having at least ...
Pregnancy acts as a ‘physiologic stress test,’ as it increases cardiac workload by 30–50% to support the foetus,” Dr Bhate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback